Here begins the text.

The 2nd Meeting of the Subcommittee on Placebo-controlled Studies

Press Release

When clicking with the mouse or pressing the tab key, Press Release is displayed.

Friday, January 9, 2015   15:00-17:00

Agenda / List of Handouts

  1. Current situation of placebo-controlled studies
  2. Others

List of Handouts

Seat Assignment

1-1.

Specialties/areas where placebo-controlled studies are difficult to conduct

1-2.

Specialties/areas where placebo-controlled studies are difficult to conduct
(Modified version of the material of #1-1 for publishing purposes)

2.

Current situation and issues of placebo-controlled studies: antidepressants

3.

Necessity of phase III placebo-controlled studies as defined in the clinical evaluation guidelines

4-1.

Recent major phase III clinical study designs for antidiabetic drugs

4-2.

Recent major phase III clinical study designs for therapeutic drugs for osteoporosis

5.

Discussion on the placebo-controlled setting in PMDA's new drug review and consultation service

 

Minutes

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000040289
0
The 2nd Meeting of the Subcommittee on Placebo-controlled Studies
/english/rs-sb-std/sb/subcommittees-2nd/placebo/0003.html
en